Finerenone API powder
CAS NO.: 1050477-31-0
Molecular formula:C21H22N4O3
Synonyms:BAY 94-8862;Finerone
Shelf life: 24 months
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 500g,1kg
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse
- Product Description
Xi'an Faithful BioTech Co., Ltd: Your Trusted Finerenone API powder Manufacturer & Supplier
As the largest Finerenone API powder supplier in the northwest region, Xi'an Faithful BioTech Co., Ltd is deeply involved in the field of API (active pharmaceutical ingredients) and focuses on the research and production of high-purity active pharmaceutical ingredients. Strict quality control is implemented throughout the entire production process, from raw material screening to ensuring the stability of product purity and productivity, in compliance with international pharmaceutical industry standards.
Finerenone API powder Introduction
Finerenone API powder is a novel mineralocorticoid receptor antagonist that has the effect of delaying the progression of chronic kidney disease. Some people may be aware of the common mineralocorticoid receptor antagonist: Eplerenone. And Finerenone is its sibling, a third-generation mineralocorticoid receptor antagonist. Xi'an Faithful BioTech Co., Ltd's Finerenone has the potential to study cardiorenal diseases such as type 2 diabetes and chronic kidney disease.We improved the process, used advanced production equipment, and improved the yield and product purity.
Specifications
| Items | Specifications | Results |
| Appearance | White Crystalline powder | Complies |
| Assay (HPLC) | ≥98.0% | 99.36% |
| Odor | Characteristic | Complies |
| Identification | Positive | Complies |
| Loss on Drying | ≤1.0% | 0.4% |
| Residue on Ignition | ≤0.15% | 0.07% |
| Individual impurity 0.1% | ≤0.1% | 0.06% |
| Total imperities | ≤1% | 0.5% |
| Total Heavy Metals | ≤20ppm | <7μg/g |
| Total Plate Count | <1000cfu/g | 60cfu/g |
| Molds and Yeasts | <100cfu/g | <10cfu/g |
| Salmonella | Negative | Complies |
| E. Coli | Negative | Complies |
| Conclusion：Conform with enterprise specification | ||
Why Choose Us?
Global customer network
Our services cover over 20 countries and regions, accumulating high-quality customer resources both domestically and internationally, and possessing mature experience in cross-border cooperation.
Industry experience and reliability
With 8 years of API supply experience, our team is professional and experienced, providing customers with stable and reliable supply chain support.
Application fields
Chronic kidney disease with type 2 diabetes
Finerenone has been approved for the treatment of chronic kidney disease patients with type 2 diabetes, especially those who have experienced a decline in renal function (eGFR 25-75 mL/min/1.73m ²) or an increase in urinary protein. Its mechanism of action is to inhibit mineralocorticoid receptors, reduce inflammation and fibrosis, and delay renal function deterioration.
Hyperkalemia management
In patients with chronic kidney disease and diabetes, Finerenone can reduce the risk of hyperkalemia, improve the tolerance of patients to other antihypertensive drugs (such as RAAS inhibitors), and thus control blood pressure and renal function more safely.
cardiovascular protection
Studies have shown that Finerenone powder may have a protective effect on the cardiovascular system, especially in patients with chronic kidney disease who also have cardiovascular disease, reducing the risk of cardiovascular events such as heart failure and myocardial infarction.
Other potential indications
Currently, clinical trials are exploring its potential applications in areas such as hypertension and heart failure, but it has not yet received widespread approval.
if you need it , you can click here
Quality Control:
R&D Results:
Packaging and Transportation:
After-Sales Service:
Qualification Certification:
Transaction Feedback:
Exhibition:
FAQ
Q1:What is the mechanism of action of finerenone?
A1:Finerenone works by acting as a selective, non-steroidal mineralocorticoid receptor (MR) antagonist. It blocks the overactivation of the MR, a receptor that binds to steroids like aldosterone, in both epithelial tissues (like the kidneys) and non-epithelial tissues (such as the heart and blood vessels). This action reduces the pro-inflammatory and pro-fibrotic effects of MR overactivation.
Q2:Does finerenone increase blood pressure?
A2: Despite its short plasma half-life, finerenone consistently reduced ambulatory systolic BP during both awake and asleep periods.
Q3:Where is the product shipped from?
A3: we usually send it from China.
Contact Us
we have high purity Finerenone API powder in stock, pls feel free to contact us , if you need it。
please contant us Email: sales12@faithfulbio.com
